ConductScience.org, home

Paper32336655

Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.

Siegler AJ and 11 others. Ann Epidemiol, 2020. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018. Papers, record 32336655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32336655

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
PubMed
Journal
Ann Epidemiol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
6.07
iCite
Revised in PubMed
2021-05-26
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Siegler AJAaron J
2Mehta CCC Christina
3Mouhanna FFarah
4Giler RMRobertino Mera
5Castel AAmanda
6Pembleton EElizabeth
7Jaggi CChandni
8Jones JJeb
9Kramer MRMichael R
10McGuinness PPema
11McCallister SScott
12Sullivan PSPatrick S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
MedicaidMajor topic
Policy MakingMajor topic
Pre-Exposure ProphylaxisMajor topic
Adult
Aged
Female
Health Policy
Humans
Local Government
Male
Middle Aged
Residence Characteristics
United States

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 AI050409NIAID NIH HHSUnited StatesP30AI050409PubMed and NIHNIH RePORTER
R01 AI143875NIAID NIH HHSUnited StatesR01AI143875PubMed and NIHNIH RePORTER
U19 HD089881NICHD NIH HHSUnited StatesU19HD089881PubMed and NIHNIH RePORTER
R01 MH114692NIMH NIH HHSUnited StatesR01MH114692PubMed and NIHNIH RePORTER
P30 AI060354NIAID NIH HHSUnited StatesP30AI060354PubMedNIH RePORTER

Download CSV of grants

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128558067Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention.PLoS One2017https://conductscience.org/library/papers/28558067PubMed
227302837Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.J Int AIDS Soc2016https://conductscience.org/library/papers/27302837PubMed
331298662Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.MMWR Morb Mortal Wkly Rep2019https://conductscience.org/library/papers/31298662PubMed
430775846Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.J Int AIDS Soc2019https://conductscience.org/library/papers/30775846PubMed
526537525The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.Med Care Res Rev2016https://conductscience.org/library/papers/26537525PubMed
631177363Implementation Strategies to Increase PrEP Uptake in the South.Curr HIV/AIDS Rep2019https://conductscience.org/library/papers/31177363PubMed
731318587Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.Am J Public Health2019https://conductscience.org/library/papers/31318587PubMed
826898645Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.Curr HIV/AIDS Rep2016https://conductscience.org/library/papers/26898645PubMed
926967306Public Health-Seattle & King County and Washington State Department of Health Preexposure Prophylaxis Implementation Guidelines, 2015.Sex Transm Dis2016https://conductscience.org/library/papers/26967306PubMed
1027418048Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.J Infect Dis2016https://conductscience.org/library/papers/27418048PubMed
1126370101A SWOT Analysis of the Updated National HIV/AIDS Strategy for the U.S., 2015-2020.AIDS Behav2016https://conductscience.org/library/papers/26370101PubMed
1232088073Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.Ann Epidemiol2020https://conductscience.org/library/papers/32088073PubMed
1326606148Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.MMWR Morb Mortal Wkly Rep2015https://conductscience.org/library/papers/26606148PubMed
1430343026Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.Lancet HIV2018https://conductscience.org/library/papers/30343026PubMed
1529983236The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.Ann Epidemiol2018https://conductscience.org/library/papers/29983236PubMed
1627851714Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.J Acquir Immune Defic Syndr2016https://conductscience.org/library/papers/27851714PubMed
1730406756Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.Ann Epidemiol2018https://conductscience.org/library/papers/30406756PubMed
1824260137Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.PLoS One2013https://conductscience.org/library/papers/24260137PubMed
1925065857Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.Lancet Infect Dis2014https://conductscience.org/library/papers/25065857PubMed
2023797289The state of engagement in HIV care in the United States: from cascade to continuum to control.Clin Infect Dis2013https://conductscience.org/library/papers/23797289PubMed

See all 22 referencesDownload CSV of references

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42658858Enhancing uptake of PrEP for her via organizational research and individual actions (EUPHORIA): Protocol for a stepped-wedge cluster randomized trial.PLoS One2026https://conductscience.org/library/papers/42658858PubMed
42427078What Tools Do We Have to End the US HIV Epidemic? A Review of Structural, Biomedical and Implementation Interventions and Their Potential Population Impact.J Int AIDS Soc2026https://conductscience.org/library/papers/42427078PubMed
41617214
Establish a PrEP (Pre-Exposure Prophylaxis) Epidemiology, Modeling, and Surveillance (PREMISE) System to Analyze Trends in PrEP Uptake and the Impact of PrEP Programs and Policies: Protocol for a Natural Experiment and Modeling Study in the United States.
JMIR Res Protoc2026https://conductscience.org/library/papers/41617214PubMed
41396185HIV Diagnosis and Preexposure Prophylaxis (PrEP) Prescription Among Commercially Insured Persons With Bipolar Disorder.J Clin Psychiatry2025https://conductscience.org/library/papers/41396185PubMed
41324957Telemedicine Preexposure Prophylaxis Prescribing From a Large Online US Company.JAMA Netw Open2025https://conductscience.org/library/papers/41324957PubMed
41223030Pre-Exposure prophylaxis knowledge, use and adherence among a US national sample of women.AIDS Care2026https://conductscience.org/library/papers/41223030PubMed
41052386Impact Of Medicaid Expansion On HIV Pre-Exposure Prophylaxis Coverage, 2012-23.Health Aff (Millwood)2025https://conductscience.org/library/papers/41052386PubMed
40932715Excess HIV Infections and Costs Associated With Reductions in HIV Prevention Services in the US.JAMA Netw Open2025https://conductscience.org/library/papers/40932715PubMed
40816951Impacts of Medicaid Expansion on Contraceptive Use Among Women in Neighborhoods of Racialized Socioeconomic Deprivation in the United States.Womens Health Issues2025https://conductscience.org/library/papers/40816951PubMed
40719963What Is the Effect of Medicaid Expansions on Preexposure Prophylaxis for HIV Prevention Use among Women?AIDS Behav2025https://conductscience.org/library/papers/40719963PubMed
40617367Mortgage discrimination at the intersection of race and sexual orientation and its association with HIV incidence among sexual minority men in the U.S.Ann Epidemiol2025https://conductscience.org/library/papers/40617367PubMed
40600487Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United States.J Int AIDS Soc2025https://conductscience.org/library/papers/40600487PubMed
40364537Inequities in PrEP annualized pill-day coverage, United States, 2018-2022: a cross-sectional pharmacoequity analysis.J Int AIDS Soc2025https://conductscience.org/library/papers/40364537PubMed
40199238Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023.J Acquir Immune Defic Syndr2025https://conductscience.org/library/papers/40199238PubMed
39781235The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021.Can Commun Dis Rep2025https://conductscience.org/library/papers/39781235PubMed
39739278County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018.AIDS Behav2025https://conductscience.org/library/papers/39739278PubMed
39734803Disparities in PrEP use and unmet need across PEPFAR-supported programs: doubling down on prevention to put people first and end AIDS as a public health threat by 2030.Front Reprod Health2024https://conductscience.org/library/papers/39734803PubMed
39628794Where do we go from here? Reconciling implementation failure of PrEP for Black women in the South. Leveraging critical realism to identify unaddressed barriers as we move forward.Front Reprod Health2024https://conductscience.org/library/papers/39628794PubMed
39556546PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA.PLoS One2024https://conductscience.org/library/papers/39556546PubMed
39141024Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study.JMIR Form Res2024https://conductscience.org/library/papers/39141024PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32336655

GET https://conductscience.org/api/papers/v1/32336655/references?page=2